A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)

NCT02483312 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: IL-12

Sponsor

University Health Network, Toronto

Collaborators

[object Object]